Education > Webinar > Navigating the Complexity of the GI Microbiome in Clinical Practice

Navigating the Complexity of the GI Microbiome in Clinical Practice

Throughout the heavy research process during the development of the GI EcologiX, there were many discoveries which we will share with you throughout this free webinar.

28th January 2020
6:30 pm GMT


At Invivo we pride ourselves in translating the wealth of complex information around the GI microbiome into clinical relevance. Patient outcomes govern what we do and with this in mind, we created a new GI profile called GI EcologiX™.

Throughout the heavy research process during development, there were many discoveries which we will share with you throughout this webinar, which we are running in collaboration with IHCAN.

Learning Objectives
  • How to use ‘systems theory’ thinking to view the human microbiome as a dynamic and contextually-rich ecosystem.
  • The importance of the GI immune system – including inflammation and antimicrobial peptides in health and disease.
  • Understand the role of ‘syntrophy’ in short-chain fatty acid (SCFA) production by commensal bacteria.
  • Learn more about the importance of Bacteroides species – the good, the bad and the ugly.
  • Understand the different roles of key Ruminococcus species in health and disease.
  • Learn about novel microbes and mycology involvement as triggers for inflammatory pathways and IBD in the GI tract.
  • The importance of molecular methodologies and endogenous gene controls in mapping the human microbiome.
  • Learn about the new comprehensive GI EcologiX™ microbiome profile from Phylo Bioscience™ (now Invivo Diagnostics Laboratory), a CQC registered UK microbiome laboratory.


  • Humphrey Bacchus

    Humphrey Bacchus is the MD at Invivo Healthcare, and founder of the UK-based microbiology lab, Phylo Bioscience. His vision for the laboratory was to develop multiple host-microbiome clinical diagnostics for healthcare professionals. His research interests focus on the microbiome-immune interface and its role in health and disease. Under his guidance, Phylo Bioscience has commercially developed and brought to market microbiome profiles assessing the gastrointestinal, oral and vaginal ecosystems, whilst also conducting research work into the oral-gut microbiome and the pathogenesis of neurodegenerative disorders.

Related Articles

Bio.Me, Microbiome
HMOs as Prebiotics to Reinforce Innate Immune System

Galactooligosaccharides (GOS) is one of our key supplements to promote a healthy microbiome for immune health and host-microbiome homeostasis.

Collaboration with University of Reading Strengthens Research and Development Activities in Gut-Brain Area

Winclove Probiotics, specialized in research, development and manufacturing of probiotic formulations, has joined forces with the University of Reading, a global university in Reading, Berkshire, England. This collaboration aims to ...

Gastrointestinal, GI EcologiX™, Microbiome, SIBO
SIBO: An Ecosystem Disorder

Recently we hosted a course on small intestinal bacterial overgrowth (SIBO) with Dr Jason Hawrelak called Demystifying SIBO. True to its name, Dr Hawrelak spoke frankly about the flaws in ...